Related Experiment Video

Updated: Jun 19, 2026

An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection
09:01

An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection

Published on: December 11, 2013

[Respiratory syncytial virus]

Lone Graff Stensballe1, Kim Kristensen

  • 1Afdeling for Epidemiologisk Forskning, Statens Serum Institut, Artillerivej 5, DK-2300 København S. lgn@ssi.dk

Ugeskrift for Laeger
|January 14, 2003
PubMed

Insights

Respiratory syncytial virus (RSV) is a common infant respiratory infection. While high-risk infants can receive palivizumab prophylaxis, most severe cases occur in healthy, full-term infants, highlighting the need for effective prevention strategies.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Virology

Context:

  • Respiratory syncytial virus (RSV) is the leading cause of lower respiratory tract infections in infants.
  • Severe RSV disease disproportionately affects high-risk groups, including preterm infants, those with chronic lung or heart conditions, and immunodeficient infants.
  • A significant number of severe RSV cases occur in otherwise healthy, full-term infants, indicating a broader public health concern.

Purpose:

  • To review the epidemiology and clinical impact of RSV in infants.
  • To discuss current prophylaxis options, including palivizumab, and their limitations.
  • To emphasize the importance of hygienic measures in preventing RSV hospitalizations.

Summary:

  • RSV infection is a major pediatric health issue, with increasing hospitalization rates and links to long-term respiratory problems like asthma.
  • While palivizumab offers protection for high-risk infants, its high cost limits widespread use.
  • Current primary prevention strategies focus on hygienic practices to prevent nosocomial RSV transmission.

Impact:

  • Highlights the growing burden of RSV on pediatric healthcare systems.
  • Underscores the need for improved and accessible preventive measures against RSV.
  • Informs clinical practice and public health policy regarding RSV management and prevention in infants.

More Related Videos

An Improved and High Throughput Respiratory Syncytial Virus (RSV) Micro-neutralization Assay09:14

An Improved and High Throughput Respiratory Syncytial Virus (RSV) Micro-neutralization Assay

Published on: January 26, 2019

Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses11:48

Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses

Published on: April 4, 2019

Related Concept Videos

Common Respiratory Disorders01:31

Common Respiratory Disorders

Respiratory disorders, a prevalent health concern globally, are generally divided into two primary categories: upper and lower respiratory tract disorders. The categorization is based on the area of the respiratory system they affect.
Upper respiratory disorders impact the airways above the vocal cords, encompassing areas like the nose, sinuses, and throat. Various conditions fall under this category, including the common cold and allergic rhinitis. These disorders can stem from several causes,...
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without causing...
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Coronavirus01:29

Coronavirus

Coronaviruses, including the severe acute respiratory syndrome coronavirus (SARS-CoV), are enveloped viruses characterized by their single-stranded, positive-sense RNA genome and helical nucleocapsid structure. The hallmark of these viruses is their club-shaped spike (S) glycoproteins that protrude from the viral envelope, facilitating attachment to host cells. Typically, coronaviruses infect the upper respiratory tract, often causing mild or asymptomatic disease. However, certain strains like...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...